ProSomnus — Company Overview, News & Financial Data
ProSomnus specializes in developing sleep apnea devices aimed at improving health and quality of life through innovative sleep therapy.
ProSomnus
About
ProSomnus (NASDAQ:OSA) specializes in developing and commercializing sleep apnea devices that are designed to improve the health and well-being of individuals suffering from sleep apnea and other sleep-related disorders. The company focuses on leveraging innovative technology and medical insights to offer solutions that enhance sleep quality, addressing a significant and growing global health issue. ProSomnus aims to redefine sleep therapy by providing less invasive, more comfortable, and highly effective treatment alternatives. Through its dedication to clinical excellence and patient satisfaction, ProSomnus strives towards improving patient outcomes and quality of life for individuals experiencing sleep disturbances, positioning itself as a pivotal player in the sleep health industry.
Snapshot
Operations
Products and/or services of ProSomnus
- Precision oral devices for treating obstructive sleep apnea, leveraging custom-fit technology to enhance patient comfort and effectiveness.
- A CPAP alternative product, designed for patients who struggle with traditional CPAP machines, offering a more comfortable and user-friendly solution.
- Digital design and manufacturing services for dental appliances, incorporating advanced algorithms to optimize treatment outcomes.
- Sleep diagnostics support tools, aimed at streamlining the process of diagnosing sleep disorders for healthcare providers.
- A comprehensive patient management platform, facilitating communication between patients and providers, as well as monitoring treatment progress.
- Research and development in sleep science, contributing to the advancement of sleep disorder treatment technologies.
ProSomnus executive team
- Mr. Leonard LiptakCo-Founder, CEO & Director
- Mr. Sung KimCo-Founder & CTO
- Ms. Laing F. RikkersCo-founder & Executive Chairman
- Mr. Brian B. DowCFO & Corporate Secretary
- Dr. John E. Remmers M.D.Chief Scientist
- Ms. Heather WhalenVice President of Global Marketing Services
- Dr. Shouresh Charkhandeh D.D.S.Global Scientific Committee Chair
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift